180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, will conduct a reverse stock split of its outstanding shares of common stock. The ratio of the reverse stock split, which is slated to go into effect on Feb. 28 with market open, will be 1-for-19. According to the announcement, the reverse stock split, which was approved by stockholders at the company’s Feb. 16 Special Meeting of Stockholders, will reduce the number of the company’s outstanding common shares from approximately 11.3 million shares to approximately 0.6 million shares. “In connection with the reverse stock split, every 19 shares of the company’s common stock issued and outstanding as of the effective time will be automatically converted into one share of the company’s common stock,” said the company in the press release. “No change will be made to the trading symbol for the company’s shares of common stock or public warrants, ATNF and ATNFW, respectively, in connection with the reverse split. The reverse stock split is part of the company’s plan to regain compliance with the minimum bid price requirement of $1 per share required to maintain continued listing on the NASDAQ Capital Market, among other benefits.”
To view the full press release, visit https://ibn.fm/YsimJ
About 180 Life Sciences Corp.
180 Life Sciences is a clinical-stage biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research and, where appropriate, combination therapy. The company’s current primary focus is a novel program to treat several inflammatory disorders using anti-TNF, or tumor necrosis factor. For more information about the company, visit www.180LifeSciences.com.
NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at https://ibn.fm/ATNF
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com
InvestorWire is powered by IBN
